Pathogenesis of lung cancer signalling pathways: roadmap for therapies
E Brambilla, A Gazdar - European Respiratory Journal, 2009 - Eur Respiratory Soc
Lung cancer is the major cancer killer worldwide, and 5-yr survival is extremely poor (≤
15%), accentuating the need for more effective therapeutic strategies. Significant advances …
15%), accentuating the need for more effective therapeutic strategies. Significant advances …
[引用][C] Pathogenesis of lung cancer signalling pathways: roadmap for therapies
E Brambilla, A Gazdar - European Respiratory Journal, 2009 - cir.nii.ac.jp
Pathogenesis of lung cancer signalling pathways: roadmap for therapies | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本を …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本を …
[PDF][PDF] Pathogenesis of lung cancer signaling pathways: roadmap for therapies
E Brambilla, A Gazdar - Eur Respir J, 2009 - researchgate.net
Lung cancer is the major cancer killer worldwide, and 5-yr survival is extremely poor (≤
15%), accentuating the need for more effective therapeutic strategies. Significant advances …
15%), accentuating the need for more effective therapeutic strategies. Significant advances …
Pathogenesis of lung cancer signalling pathways: roadmap for therapies.
E Brambilla, A Gazdar - The European Respiratory Journal, 2009 - europepmc.org
Pathogenesis of lung cancer signalling pathways: roadmap for therapies. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …
[HTML][HTML] Pathogenesis of lung cancer signaling pathways: roadmap for therapies
E Brambilla, A Gazdar - … respiratory journal: official journal of the …, 2009 - ncbi.nlm.nih.gov
Pathogenesis of lung cancer signaling pathways: roadmap for therapies - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
[PDF][PDF] Pathogenesis of lung cancer signalling pathways: roadmap for therapies
E Brambilla, A Gazdar - EUROPEAN RESPIRATORY JOURNAL, 2009 - Citeseer
Lung cancer is the major cancer killer worldwide, and 5-yr survival is extremely poor (f15%),
accentuating the need for more effective therapeutic strategies. Significant advances in lung …
accentuating the need for more effective therapeutic strategies. Significant advances in lung …
Pathogenesis of lung cancer signalling pathways: roadmap for therapies
E Brambilla, A Gazdar - The European respiratory journal, 2009 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the major cancer killer worldwide, and 5-yr survival is extremely poor (< or=
15%), accentuating the need for more effective therapeutic strategies. Significant advances …
15%), accentuating the need for more effective therapeutic strategies. Significant advances …
[引用][C] Pathogenesis of lung cancer signalling pathways: roadmap for therapies
E BRAMBILLA, A GAZDAR - The European respiratory journal, 2009 - pascal-francis.inist.fr
Pathogenesis of lung cancer signalling pathways: roadmap for therapies CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pathogenesis of lung cancer signalling pathways: Roadmap for therapies
E Brambilla, A Gazdar - European …, 2009 - utsouthwestern.elsevierpure.com
Lung cancer is the major cancer killer worldwide, and 5-yr survival is extremely poor (≤
15%), accentuating the need for more effective therapeutic strategies. Significant advances …
15%), accentuating the need for more effective therapeutic strategies. Significant advances …
Pathogenesis of lung cancer signalling pathways: roadmap for therapies
E Brambilla, A Gazdar - European Respiratory Journal, 2009 - hero.epa.gov
Lung cancer is the major cancer killer worldwide, and 5-yr survival is extremely poor (<=
15%), accentuating the need for more effective therapeutic strategies. Significant advances …
15%), accentuating the need for more effective therapeutic strategies. Significant advances …